Document Detail


Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
MedLine Citation:
PMID:  17971645     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this paper, an overview is given of trials with oral anticoagulants and dipyridamole in the secondary prevention after transient ischaemic attack or minor stroke. In patients with atrial fibrillation, the secondary preventive treatment of first choice is oral anticoagulation with an aimed international normalised ratio between 2.0 and 3.0. In patients without a cardiac source of embolism, a combination therapy of low-dose aspirin and dipyridamole 200 mg twice daily is the treatment of choice. These treatment strategies do however not prevent all recurrent strokes or vascular complications, and research for more effective strategies is warranted.
Authors:
P H A Halkes; A Algra
Related Documents :
3401095 - Age-related risks of long-term oral anticoagulant therapy.
12968085 - Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial ...
20556385 - Optease vena cava filter optimal indwelling time and retrievability.
9723825 - A new regimen for starting warfarin therapy in out-patients.
8020175 - Ceftriaxone in prevention of complications after cesarean section and its influence on ...
11476305 - Is titanium so bad? medium-term outcome of cemented titanium stems.
Publication Detail:
Type:  Journal Article; Review     Date:  2007-11-01
Journal Detail:
Title:  Cerebrovascular diseases (Basel, Switzerland)     Volume:  24 Suppl 1     ISSN:  1015-9770     ISO Abbreviation:  Cerebrovasc. Dis.     Publication Date:  2007  
Date Detail:
Created Date:  2007-10-31     Completed Date:  2008-01-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9100851     Medline TA:  Cerebrovasc Dis     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  107-11     Citation Subset:  IM    
Copyright Information:
Copyright 2007 S. Karger AG, Basel.
Affiliation:
Department of Neurology, Rudolf Magnus Institute of Neuroscience, Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Aspirin / therapeutic use*
Brain Ischemia / prevention & control*
Dipyridamole / therapeutic use*
Humans
Platelet Aggregation Inhibitors / therapeutic use*
Stroke / prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary...
Next Document:  Usefulness of antiplatelet drugs in ischaemic stroke prevention--update on new trials.